"Comparing the excess of serious AESI against the reduction of serious complications of COVID296 19 among the vaccinated is essential for harm-benefit analyses. The results show an excess 297 risk of serious AESIs greater than the reduction in COVID-19 hospitalizations in both Pfizer and 298 Moderna trials. These results are compatible with a recent preprint analysis of COVID-19 299 vaccine trials by Benn et al., which found no evidence of a reduction in overall mortality in the 300 mRNA vaccine trials ... "
delivery.php (ssrn.com)